Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells

Kelly B Arnold, Adam Burgener, Kenzie Birse, Laura Romas, Laura J Dunphy, Kamnoosh Shahabi, Max Abou, Garrett R Westmacott, Stuart McCorrister, Jessie Kwatampora, Billy Nyanga, Joshua Kimani, Lindi Masson, Lenine J Liebenberg, Salim S Abdool Karim, Jo-Ann S Passmore, Douglas A Lauffenburger, Rupert Kaul, Lyle R McKinnon, Kelly B Arnold, Adam Burgener, Kenzie Birse, Laura Romas, Laura J Dunphy, Kamnoosh Shahabi, Max Abou, Garrett R Westmacott, Stuart McCorrister, Jessie Kwatampora, Billy Nyanga, Joshua Kimani, Lindi Masson, Lenine J Liebenberg, Salim S Abdool Karim, Jo-Ann S Passmore, Douglas A Lauffenburger, Rupert Kaul, Lyle R McKinnon

Abstract

Elevated inflammatory cytokines (EMCs) at mucosal surfaces have been associated with HIV susceptibility, but the underlying mechanisms remain unclear. We characterized the soluble mucosal proteome associated with elevated cytokine expression in the female reproductive tract. A scoring system was devised based on the elevation (upper quartile) of at least three of seven inflammatory cytokines in cervicovaginal lavage. Using this score, HIV-uninfected Kenyan women were classified as either having EMC (n=28) or not (n=68). Of 455 proteins quantified in proteomic analyses, 53 were associated with EMC (5% false discovery rate threshold). EMCs were associated with proteases, cell motility, and actin cytoskeletal pathways, whereas protease inhibitor, epidermal cell differentiation, and cornified envelope pathways were decreased. Multivariate analysis identified an optimal signature of 16 proteins that distinguished the EMC group with 88% accuracy. Three proteins in this signature were neutrophil-associated proteases that correlated with many cytokines, especially GM-CSF (granulocyte-macrophage colony-stimulating factor), IL-1β (interleukin-1β), MIP-3α (macrophage inflammatory protein-3α), IL-17, and IL-8. Gene set enrichment analyses implicated activated immune cells; we verified experimentally that EMC women had an increased frequency of endocervical CD4(+) T cells. These data reveal strong linkages between mucosal cytokines, barrier function, proteases, and immune cell movement, and propose these as potential mechanisms that increase risk of HIV acquisition.

References

    1. Hum Reprod. 2000 Aug;15 Suppl 3:112-9
    1. Biol Reprod. 2004 Sep;71(3):761-9
    1. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
    1. J Immunol. 2013 Sep 1;191(5):2164-73
    1. Nat Rev Immunol. 2009 Dec;9(12):883-9
    1. J Leukoc Biol. 2007 Mar;81(3):686-95
    1. Lancet Infect Dis. 2008 Sep;8(9):553-63
    1. J Innate Immun. 2014;6(1):13-20
    1. Sci Signal. 2011 Mar 22;4(165):ra16
    1. J Exp Med. 2012 Aug 27;209(9):1595-609
    1. J Infect Dis. 2001 Aug 15;184(4):418-28
    1. J Exp Med. 2004 Sep 20;200(6):749-59
    1. Viral Immunol. 2014 Jun;27(5):200-6
    1. J Exp Med. 2004 Sep 20;200(6):761-70
    1. PLoS One. 2014 Jan 15;9(1):e85675
    1. N Engl J Med. 1983 Aug 25;309(8):453-8
    1. Nucleic Acids Res. 2009 Jan;37(1):1-13
    1. PLoS Med. 2011 Feb 15;8(2):e1000416
    1. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5640-5
    1. AIDS. 2008 Oct 1;22(15):2049-51
    1. Lancet Infect Dis. 2009 Feb;9(2):118-29
    1. J Invest Dermatol. 2005 May;124(5):990-7
    1. Contraception. 2006 Aug;74(2):133-40
    1. J Immunol. 2014 Feb 15;192(4):1718-31
    1. Cell Tissue Res. 2007 Apr;328(1):197-206
    1. J Leukoc Biol. 2007 Apr;81(4):1022-31
    1. Nat Med. 2008 Apr;14(4):421-8
    1. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):6-12
    1. J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3:S184-93
    1. J Infect Dis. 2014 Oct 15;210(8):1239-47
    1. AIDS. 2011 Mar 27;25(6):741-9
    1. J Virol. 2013 May;87(9):5141-50
    1. Sex Transm Infect. 2014 Dec;90(8):580-7
    1. J Proteome Res. 2011 Nov 4;10(11):5139-49
    1. Reproduction. 2001 Jan;121(1):3-19
    1. PLoS One. 2014 Jun 30;9(6):e100820
    1. Immunity. 2013 Oct 17;39(4):633-45
    1. Stat Med. 1997 Feb 28;16(4):385-95
    1. Nat Rev Immunol. 2013 Mar;13(3):159-75
    1. Mucosal Immunol. 2014 Nov;7(6):1375-85
    1. Nat Med. 2006 Dec;12(12):1365-71
    1. Nature. 2009 Apr 23;458(7241):1034-8
    1. Nat Immunol. 2013 Sep;14 (9):949-58
    1. Biol Reprod. 2012 Feb 09;86(2):32
    1. J Immunol. 2011 Dec 1;187(11):6032-42
    1. J Infect Dis. 2012 Jul 1;206(1):6-14
    1. Nat Protoc. 2009;4(1):44-57
    1. Int J Cell Biol. 2012;2012:935173
    1. AIDS. 2009 Jan 28;23 (3):309-17
    1. Annu Rev Med. 2009;60:471-84
    1. J Immunol. 2013 Sep 15;191(6):3430-9
    1. PLoS Pathog. 2014 Oct 02;10(10):e1004416
    1. PLoS Med. 2008 Oct 21;5(10):e203
    1. Curr Top Microbiol Immunol. 2013;363:201-33
    1. Science. 2014 Oct 3;346(6205):98-101
    1. J Infect Dis. 1999 Apr;179(4):859-70
    1. J Infect Dis. 2012 Jan 15;205(2):194-203
    1. Hum Reprod. 1992 Oct;7(9):1214-21
    1. AIDS. 2012 Sep 24;26(15):1857-67
    1. Am J Reprod Immunol. 2014 Jun;71(6):618-23

Source: PubMed

3
Předplatit